Zaccardelli David's Form 4 filing
Verona Pharma plc (VRNA) · filed Sep 13, 2024
- Accession no.
- 0001104659-24-099794
- Filed
- Sep 13, 2024
- Trade date
- Sep 11, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction. Open-market sales total $2.26M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Zaccardelli DavidCIK 0001627642 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2024 | Ordinary Shares | SSaleDisposed | −600,000 | $3.76 | −$2,256,000 | 15,250,704 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.